Strategy for the discovery and development of a positive inotropic agent.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000758:Anesthesia; D000818:Animals; D002301:Cardiac Glycosides / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007476:Ionophores / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D013268:Stimulation, Chemical
D000318:Adrenergic beta-Agonists; D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D007476:Ionophores; D010726:Phosphodiesterase Inhibitors